Abstract P4-08-02: LOXO-783: A Potent, Highly Mutant Selective and Brain-Penetrant Allosteric PI3Kα H1047R Inhibitor in Combination with Standard of Care (SOC) Treatments in Preclinical PI3Kα H1047R-mutant Breast Cancer Models
Cancer Research(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined